BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21070905)

  • 1. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness.
    Costantini M; Belli P; Rinaldi P; Bufi E; Giardina G; Franceschini G; Petrone G; Bonomo L
    Clin Radiol; 2010 Dec; 65(12):1005-12. PubMed ID: 21070905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the apparent diffusion coefficient value and dynamic magnetic resonance imaging findings with prognostic factors in invasive ductal carcinoma.
    Jeh SK; Kim SH; Kim HS; Kang BJ; Jeong SH; Yim HW; Song BJ
    J Magn Reson Imaging; 2011 Jan; 33(1):102-9. PubMed ID: 21182127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive ductal carcinoma: correlation of apparent diffusion coefficient value with pathological prognostic factors.
    Razek AA; Gaballa G; Denewer A; Nada N
    NMR Biomed; 2010 Jul; 23(6):619-23. PubMed ID: 20232453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions].
    Xie CM; Yin SH; Li H; Liu XW; Zhang Y; Lü YC; Zhang R; Li JP; Geng ZJ; Wu PH
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):217-20. PubMed ID: 20450592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted MRI evaluation of breast cancer extension.
    Long-Hua Q; Qin X; Wen-Tao Y; Feng T; Kun-Wei S; Bin W; Ya-Jia G
    Clin Imaging; 2010; 34(2):89-96. PubMed ID: 20189070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging of breast cancer: correlation of the apparent diffusion coefficient value with prognostic factors.
    Kim SH; Cha ES; Kim HS; Kang BJ; Choi JJ; Jung JH; Park YG; Suh YJ
    J Magn Reson Imaging; 2009 Sep; 30(3):615-20. PubMed ID: 19711411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characteristics of ductal carcinoma in situ (DCIS) in dynamic breast MRI using computer-assisted analysis.
    Vag T; Baltzer PA; Dietzel M; Benndorf M; Gajda M; Camara O; Kaiser WA
    Acta Radiol; 2010 Nov; 51(9):955-61. PubMed ID: 20942728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion weighted MR imaging of the breast.
    Abdel Razek AA; Gaballa G; Denewer A; Tawakol I
    Acad Radiol; 2010 Mar; 17(3):382-6. PubMed ID: 20004597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of ductal carcinoma in situ of the breast.
    Yoshida M; Kinoshita T
    Jpn J Clin Oncol; 2009 Feb; 39(2):132. PubMed ID: 19155284
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of ductal carcinoma in situ in magnetic resonance imaging.
    Facius M; Renz DM; Neubauer H; Böttcher J; Gajda M; Camara O; Kaiser WA
    Clin Imaging; 2007; 31(6):394-400. PubMed ID: 17996602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differential atypical ductal hyperplasia/DCIS/invasive carcinoma diagnosis and significance of micrometastases].
    Stosiek P
    Zentralbl Chir; 1998; 123 Suppl 5():13. PubMed ID: 10063563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine ductal carcinoma in situ of the breast: cytological features in 32 cases.
    Kawasaki T; Nakamura S; Sakamoto G; Kondo T; Tsunoda-Shimizu H; Ishii Y; Nakazawa T; Mochizuki K; Yamane T; Inoue M; Inoue S; Katoh R
    Cytopathology; 2011 Feb; 22(1):43-9. PubMed ID: 20236292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer.
    Hoque A; Menter DG; Sahin AA; Sneige N; Lippman SM
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):153-4. PubMed ID: 11219775
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feature extraction and classification of dynamic contrast-enhanced T2*-weighted breast image data.
    Torheim G; Godtliebsen F; Axelson D; Kvistad KA; Haraldseth O; Rinck PA
    IEEE Trans Med Imaging; 2001 Dec; 20(12):1293-301. PubMed ID: 11811829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In situ ductal carcinoma of the breast].
    Peña-Estévez VL; Aguilar U; Torrescano Granillo A
    Ginecol Obstet Mex; 1999 Feb; 67():43-9. PubMed ID: 10327763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of PROPELLER diffusion weighted imaging and apparent diffusion coefficient in the diagnosis of sellar and parasellar lesions.
    Mahmoud OM; Tominaga A; Amatya VJ; Ohtaki M; Sugiyama K; Saito T; Sakoguchi T; Kinoshita Y; Shrestha P; Abe N; Akiyama Y; Takeshima Y; Arita K; Kurisu K; Yamasaki F
    Eur J Radiol; 2010 Jun; 74(3):420-7. PubMed ID: 19394778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors.
    Belli P; Costantini M; Bufi E; Giardina GG; Rinaldi P; Franceschini G; Bonomo L
    Radiol Med; 2015 Mar; 120(3):268-76. PubMed ID: 25096888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.